Investments
21Portfolio Exits
1About Spruce Capital Partners
The principals and founders of Spruce Capital Partners, Dr. Ganesh Kishore, Dr. Roger Wyse, and Greg Young, are well known investors and thought leaders in the biogreentech sector. They bring a wealth of experience as investors, advisers, and domain experts in helping entrepreneurs build the next generation of successful biogreentech companies. They formed Spruce Capital Partners not only to manage venture funds, but also to develop new talent for the industry, provide thought leadership, and promote innovation in companies and countries. The principals have worked together for more than 10 years and have shepherded investments across multiple funds and multiple sectors. They are also active in advising, partnering, and shaping the life sciences industry globally and, especially in Malaysia and United States. Spruce Capital Partners is a co-manager of the MLS Capital Fund II. Additional information is available at www.sprucecp.com.
Spruce Capital Partners Headquarter Location
100 Montgomery St Suite 2190
San Francisco, California, 94103,
United States
Expert Collections containing Spruce Capital Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Spruce Capital Partners in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest Spruce Capital Partners News
May 19, 2022
Israeli team formation startup A.Team , emerged from stealth mode this week to announce the completion of a $55 million Series A financing round on top of a previously undisclosed $5 million seed round to expand its network of product builders and client base. The newest round was co-led by investment firms Tiger Global Management, Insight Partners, and Spruce Capital Partners. A.Team aims to exponentially scale its current $42 million gross merchandise value (GMV) by continuing to grow its product builder network and investing in its demand growth initiatives. Founded in 2020 in the wake of the COVID-19 pandemic and the subsequent transition to widespread remote work, A.Team developed an on-demand team formation platform that grants companies access to a vast members-only network of highly skilled product builders ranging from engineers, product managers, designers, data scientists, and marketing talent to accelerate their respective product development. Builders can apply to A.Team as a team or as an individual and can start interacting with the platform only after they undergo a rigorous vetting process. Only then can they start creating a team of people they enjoy working with or join an ad-hoc team for a company mission. The startup established a network of 4,000 product builders and aided more than 200 companies such as American publishing company McGraw Hill , Israeli multinational multi-investment company eToro , American law firm Morgan & Morgan , women-oriented private membership network Chief , as well as a host of startup, growth, and enterprise companies throughout the U.S and Israel while in stealth mode. With the rising demand for ready-to-deploy tech talent, A.Team has grown 7x in the past year. “We founded A.Team because there’s nothing more powerful than having the freedom to choose to work on problems that matter to you with people you love to work with,” said CEO and co-founder Raphael Ouzan. “Every idea that’s ever changed the world has had a great team behind it. Yet, teams—the core unit of work in the knowledge economy—has never been optimized with technology. With cloud-based teams, we’re unlocking the ability for highly-skilled professionals to escape rigid structures and team up to do the most meaningful work of their career—and transform the way that companies build in the process.” “A.Team is the rare startup that could fundamentally change how we work,” said A.Team advisor, organizational psychologist, and bestselling author Adam Grant. “COVID made it clear that we need to rethink work, but it’s much bigger than just letting people work from anywhere. A.Team is reinventing the way we organize in the knowledge and creative economy by empowering people to pick their projects and teammates—and empowering companies to hire top talent on-demand. Instead of selling your soul to one company, you can rent your skills to the highest bidder or the highest purpose.” Subscribe to NoCamels weekly newsletter and get our top stories
Spruce Capital Partners Investments
21 Investments
Spruce Capital Partners has made 21 investments. Their latest investment was in Greenlight Biosciences as part of their PIPE on February 2, 2022.
Spruce Capital Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
2/3/2022 | PIPE | Greenlight Biosciences | $105M | No | 1 | |
2/8/2021 | Series D | Evolve BioSystems | $65M | No | 2 | |
2/8/2021 | Series B | Amfora | $6M | No | 3 | |
1/25/2021 | Seed VC | |||||
12/22/2020 | Series C - II |
Date | 2/3/2022 | 2/8/2021 | 2/8/2021 | 1/25/2021 | 12/22/2020 |
---|---|---|---|---|---|
Round | PIPE | Series D | Series B | Seed VC | Series C - II |
Company | Greenlight Biosciences | Evolve BioSystems | Amfora | ||
Amount | $105M | $65M | $6M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 1 | 2 | 3 |
Spruce Capital Partners Portfolio Exits
1 Portfolio Exit
Spruce Capital Partners has 1 portfolio exit. Their latest portfolio exit was Greenlight Biosciences on February 03, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
2/3/2022 | Reverse Merger | 3 |
Date | 2/3/2022 |
---|---|
Exit | Reverse Merger |
Companies | |
Valuation | |
Acquirer | |
Sources | 3 |
Spruce Capital Partners Team
4 Team Members
Spruce Capital Partners has 4 team members, including current Founder, Managing Partner, Roger E. Wyse.
Name | Work History | Title | Status |
---|---|---|---|
Roger E. Wyse | Burrill & Company, Burrill & Company, University of Wisconsin-Madison, and Rutgers University | Founder, Managing Partner | Current |
Ganesh Kishore | Managing Partner | Current | |
Ganesh Kishore | Managing Partner | Current | |
Greg Young | Malaysian Life Sciences Capital Fund, and Celgene | Managing Partner | Current |
Name | Roger E. Wyse | Ganesh Kishore | Ganesh Kishore | Greg Young |
---|---|---|---|---|
Work History | Burrill & Company, Burrill & Company, University of Wisconsin-Madison, and Rutgers University | Malaysian Life Sciences Capital Fund, and Celgene | ||
Title | Founder, Managing Partner | Managing Partner | Managing Partner | Managing Partner |
Status | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.